Benign Karaciğer Lezyonları

Sadick, M.; Müller-Wille, R.; Wildgruber, M.; Wohlgemuth, W.A. Vascular anomalies (part I): Classification and diagnostics of vascular anomalies. Rofo 2018, 190, 825–835.

Belghiti, J.; Cauchy, F.; Paradis, V.; Vilgrain, V. Diagnosis and management of solid benign liver lesions. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 737–749.

Leon, M.; Chavez, L.; Surani, S. Hepatic hemangioma: What internists need to know. World J. Gastroenterol. 2020, 26, 11–20.

Dockerty, M.B.; Gray, H.K.; Henson, S.W. Benign tumors of the liver. II. Hemangiomas. Surg. Gynecol. Obstet. 1956, 103, 327–331.

Oak, C.Y.; Jun, C.H.; Cho, E.A.; Lee, D.H.; Cho, S.B.; Park, C.H.; Joo, Y.E.; Kim, H.S.; Rew, J.S.; Choi, S.K. Hepatic Hemangioma with Kasabach-Merritt Syndrome in an Adult Patient. Korean J. Gastroenterol. 2016, 67, 220–223.

Aslan, A.; Meyer Zu Vilsendorf, A.; Kleine, M.; Bredt, M.; Bektas, H. Adult Kasabach-Merritt Syndrome due to Hepatic Giant Hemangioma. Case Rep. Gastroenterol. 2009, 3, 306–312.

Aziz, H.; Brown, Z.J.; Baghdadi, A.; Kamel, I.R.; Pawlik, T.M. A comprehensive review of hepatic hemangioma management. J. Gastrointest. Surg. 2022, 26, 1998–2007.

Oldhafer, K.J.; Habbel, V.; Horling, K.; Makridis, G.; Wagner, K.C. Benign Liver Tumors. Visc. Med. 2020, 36, 292–303.

Farhat, W.; Ammar, H.; Said, M.A.; Mizouni, A.; Ghabry, L.; Hammami, E.; Gupta, R.; Habiba Ben Hamada; Mabrouk, M.B.; Ali, A.B. Surgical management of giant hepatic hemangioma: A 10-year single center experience. Ann. Med. Surg. 2021, 69, 102542.

Craig, J.R.; Peters, R.L.; Edmondson, H.A. Tumors of the Liver and Intrahepatic Bile Ducts. In Atlas of Tumor Pathology; Armed Forces Institute of Pathology: Washington, DC, USA, 1989.

Wanless, I.R.; Mawdsley, C.; Adams, R. On the Pathogenesis of Focal Nodular Hyperplasia of the Liver. Hepatology 1985, 5, 1194–1200.

Herman P, Pugliese V, Machado MA, Montagnini AL, Salem MZ, Bacchella T, D'Albuquerque LA, Saad WA, Machado MC, Pinotti HW. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg. 2000 Mar;24(3):372-6.

Fukahori, S.; Kawano, T.; Obase, Y.; Umeyama, Y.; Sugasaki, N.; Kinoshita, A.; Fukushima, C.; Yamakawa, M.; Omagari, K.; Mukae, H. Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use. Am. J. Case Rep. 2019, 20, 1124–1127.

Ashhab, A.A.; Abu-Sulb, A.; Yang, J.D.; Noureddin, M.; Sundaram, V.; Kuo, A.; Ayoub, W.S. Estrogen-Driven Growth of Focal Nodular Hyperplasia: Truth or Myth? ACG Case Rep. J. 2021, 8, e00531.

Virgilio, E.; Cavallini, M. Managing Focal Nodular Hyperplasia of the Liver: Surgery or Minimally-Invasive Approaches? A Review of the Preferable Treatment Options. Anticancer Res. 2018, 38, 33–36.

Cheng, Z.; Liang, P.; Yu, X.; Han, Z.; Liu, F.; Yu, J.; Li, X. Percutaneous Microwave Ablation for Benign Focal Liver Lesions: Initial Clinical Results. Oncol. Lett. 2017, 13, 429–434.

Martin NM, Abu Dayyeh BK, Chung RT. Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage. World J Gastroenterol. 2008 Jul;14((28)):4573–5. doi: 10.3748/wjg.14.4573.

Bunchorntavakul C, Bahirwani R, Drazek D, Soulen MC, Siegelman ES, Furth EE, et al. Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther. 2011 Sep;34((6)):664–74. doi: 10.1111/j.1365-2036.2011.04772.x.

Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007 Sep;46((3)):740–8. doi: 10.1002/hep.21743.

van Aalten SM, de Man RA, IJzermans JN, Terkivatan T. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg. 2012 Jul;99((7)):911–6. doi: 10.1002/bjs.8762.

Steiner P. E., “Nodular Regenerative Hyperplasia of the Liver,” American Journal Of Pathology 35 (1959): 943–953.

Wanless I. R., “Micronodular Transformation (Nodular Regenerative Hyperplasia) of the Liver: A Report of 64 Cases Among 2,500 Autopsies and a New Classification of Benign Hepatocellular Nodules,” Hepatology 11, no. 5 (1990): 787–797, 10.1002/hep.1840110512.